Darren Hatch, OD
Optometrist · Rexburg, IDNPI 1487681292
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Alcon accounts for 62.1% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $187 and has fallen 78.3% since, to $41 in 2025.
Across 40 payments — averaging $18.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$463
- Bausch & Lomb Americas Inc.$70
- Bausch & Lomb, A Division Of Bausch Health US, LLC$62
- Coopervision Inc.$49
- ABB Con-cise Optical Group LLC$35
- Optos, Inc.$29
- plus $39 from 2 others
What the payments were for
- Food & beverage$746100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 25 | $463 |
| Bausch & Lomb Americas Inc. | 4 | $70 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $62 |
| Coopervision Inc. | 3 | $49 |
| ABB Con-cise Optical Group LLC | 1 | $35 |
| Optos, Inc. | 1 | $29 |
| Synergeyes, Inc. | 1 | $26 |
| Johnson & Johnson Vision Care, Inc. | 1 | $12 |
How this compares
$746 in reported general payments places this provider in the 55th percentile of 304 optometrist providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 23 | $654 |
| Latanoprost | 28 | $241 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 15 | $186 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Rexburg
- Marshall MerrellRexburg$6K
- Nathan MortensenRexburg$2K
- Drew DaytonIdaho Falls$198K
- Philip RaineyBoise$175K
- Lavar KofoedBoise$91K
- William BlackCaldwell$67K
- Jason BeseckerMeridian$29K
- Mark McKellNampa$9K
- Douglas AdamsCaldwell$6K
- Amber SimonsonBoise$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.